The Frequency of Extended-spectrum Beta-lactamase and The Rate of Antibiotic Resistance in Escherichia coli Strains
| Autor: | Behiye Dede, Senol Comoglu, Ayten Kadanali, Gül Karagöz, Mehmet Fatih Bektaşoğlu, Fatma Muhterem Yücel |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
Imipenem
medicine.medical_treatment lcsh:Medicine Tigecycline Biology medicine.disease_cause Meropenem Microbiology chemistry.chemical_compound Antibiotic resistance medicine polycyclic compounds Escherichia coli lcsh:R Public Health Environmental and Occupational Health biochemical phenomena metabolism and nutrition bacterial infections and mycoses chemistry ESBL Amikacin Antibiotic Resistance Beta-lactamase bacteria Ertapenem medicine.drug |
| Zdroj: | TAF Preventive Medicine Bulletin, Vol 12, Iss 3, Pp 291-296 (2013) |
| Popis: | Background The resistance related with production of extended-spectrum beta-lactamase (ESBL) is an important problem that we face when we are treating infections caused by enterobacteriaceae. We aimed to evaluate the frequency of ESBL production in E. coli strains and the rate of antibiotic resistance isolated from in our microbiology laboratory. Method E. coli strains isolated from various clinical specimens between January 2010 – December 2011 were assessed retrospectively. Resistances to ESBL-producing and non-producing E. coli and the rate of ESBL production according to the years were investigated. The results were compared with statistical analysis. Results The rate of ESBL producing E. coli was 21.9% in 2010, and 25% in 2011. There was no resistance to imipenem, meropenem, ertapenem and tigecycline in all strains. The resistance to antibiotics other than amikacin was statistically significant in ESBL producing E. coli compared to ESBL non-producing E.coli (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|